Real-World Evidence and Market Access Conference

• Updates on European regulatory frameworks governing real-world evidence (RWE) and their impact on market access strategies.
• Ensuring the reliability, validity, and relevance of RWE in the context of market access.
• Effective collaboration strategies between industry stakeholders and payers to enhance market access outcomes.
• Strategies for pricing and reimbursement that align with evidence-based market access approaches.
• The impact of patient-reported outcomes on demonstrating product value and effectiveness.
• The role of health economics in demonstrating the economic value of healthcare interventions.

• Learn about the recent trends and advancements in Real-World Evidence Generation
• Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
• Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers

From pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-

• Real-World Evidence
• Real-World Data
• Data Analytics
• Health Economics & Outcomes Research- HEOR
• Market Access/Value Access
• Policy
• Clinical Development & research
• Clinical trial
• Centre for Observational and Real-World Evidence  
• Epidemiology
• Oncology-RWE
• Pricing and Reimbursement
• Medical Affairs
• Pharmacovigilance
• Life Science Analytics
• Big data
• Data Science
• Bio-Statistics
• Consumer Healthcare

Other

Payers, Regulators, Research Institutes, and Innovation Centre